Literature DB >> 2456703

A severe coagulopathy following volume replacement with hydroxyethyl starch in a Jehovah's Witness.

D N Lockwood1, C Bullen, S J Machin.   

Abstract

Blood volume was maintained by an infusion of hydroxyethyl starch 2000 ml (Hespan: HES) during and for the first 28 hours after a major orthopaedic operation in a 13-year-old girl who was a Jehovah's Witness. This was responsible for a generalised clinical haemorrhagic state, an acquired coagulopathy associated with a shortened thrombin, prolonged prothrombin and activated partial thromboplastin times, and an acquired von Willebrand syndrome. The coagulation, after cessation of the infusion of HES, did not become normal until approximately 72 hours later.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2456703     DOI: 10.1111/j.1365-2044.1988.tb09021.x

Source DB:  PubMed          Journal:  Anaesthesia        ISSN: 0003-2409            Impact factor:   6.955


  9 in total

1.  Perioperative Management of a Jehovah's Witness Presenting for Skull Base Surgery.

Authors:  M A Chaney; W S Jellish; J P Leonetti
Journal:  Skull Base Surg       Date:  1996

Review 2.  Intravenous volume replacement: which fluid and why?

Authors:  L Huskisson
Journal:  Arch Dis Child       Date:  1992-05       Impact factor: 3.791

Review 3.  Adverse reactions to plasma volume expanders.

Authors:  M M Fisher; P W Brady
Journal:  Drug Saf       Date:  1990 Mar-Apr       Impact factor: 5.606

4.  Influence of different volume therapies on platelet function in the critically ill.

Authors:  J Boldt; M Müller; M Heesen; O Heyn; G Hempelmann
Journal:  Intensive Care Med       Date:  1996-10       Impact factor: 17.440

5.  Comparison of hetastarch to albumin for perioperative bleeding in patients undergoing abdominal aortic aneurysm surgery. A prospective, randomized study.

Authors:  M S Gold; J Russo; M Tissot; G Weinhouse; T Riles
Journal:  Ann Surg       Date:  1990-04       Impact factor: 12.969

6.  Low molecular weight hydroxyethyl starch 6% compared to albumin 4% during intentional hemodilution.

Authors:  J F Baron; D De Kegel; A C Prost; O Mundler; M Arthaud; G Basset; G Maistre; F Masson; A Carayon; C Landault
Journal:  Intensive Care Med       Date:  1991       Impact factor: 17.440

7.  The effect of hydroxyethyl starch and other plasma volume substitutes on endothelial cell activation; an in vitro study.

Authors:  R E Collis; P W Collins; C N Gutteridge; A Kaul; A C Newland; D M Williams; A R Webb
Journal:  Intensive Care Med       Date:  1994       Impact factor: 17.440

8.  Acquired pseudo-pseudo Bernard-Soulier syndrome complicating Gaucher's disease.

Authors:  H Kelsey; C Christopoulos; A A Gray; S J Machin
Journal:  J Clin Pathol       Date:  1994-02       Impact factor: 3.411

9.  Evaluation of the effect of colloid (Haemaccel) on the bleeding time in the trauma patient.

Authors:  P A Evans; M Garnett; K Boffard; E Kirkman; B F Jacobson
Journal:  J R Soc Med       Date:  1996-02       Impact factor: 18.000

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.